CP-39,332

DB09193ExperimentalSmall molecule

CP-39,332 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is part of a group of monoamine reuptake inhibitor stereoisomers including tametraline (1R,4S-), CP-24,442 (1S,4R-), CP-22,185 (cis-), and CP-22,186 that show varying... However, none of the members of this stereoisomers has been marketed.

Formula / weight: C₁₇H₁₉N · 237.346 g/mol (avg)
Code names: CP-39,332

Resolves to

Compound

UNIIR0YEK8P3H4CAS61764-60-1ChEMBLCHEMBL104444PubChem15657209

Structure

InChIKeyHLOCJJORRHQDKS-UHFFFAOYSA-NSMILESCNC1CC(C2=CC=CC=C2)C2=CC=CC=C2C1

What you can answer from here — as of April 02, 2025

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of CP-39,332, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account